Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

  • End date
    Dec 25, 2025
  • participants needed
  • sponsor
    xiang yang
Updated on 25 January 2021
serum bilirubin


The investigators conducted a randomized trial to study how well multi-day methotrexate protocol works compared to biweekly single-dose actinomycin D protocol in treating patients with low-risk gestational trophoblastic neoplasia. It is not yet known whether multi-day methotrexate protocol is as effective as biweekly single-dose actinomycin D protocol in treating patients with gestational trophoblastic neoplasia.

Condition Choriocarcinoma, Invasive hydatidiform mole, Adenocarcinoma, Gestational trophoblastic disease, Stage II Gestational Trophoblastic Tumor, Stage III Gestational Trophoblastic Tumor, Malignant Adenoma, Gestational Trophoblastic Neoplasia, Stage I Gestational Trophoblastic Tumor
Treatment methotrexate, dactinomycin, Leucovorin
Clinical Study IdentifierNCT04562558
Sponsorxiang yang
Last Modified on25 January 2021


Yes No Not Sure

Inclusion Criteria

Histologically proven low-risk gestational trophoblastic neoplasia (persistent hydatidiform mole or choriocarcinoma), defined as 1 of the following
Less than 10% decrease in the beta human chorionic gonadotropin (HCG) titer over 3 weekly titers
Greater than 20% sustained rise in beta HCG titer over two consecutive weeks
Histologically proven choriocarcinoma
Stage I - III disease
WHO risk score 0-4
No prior chemotherapy for gestational trophoblastic neoplasia
Signed informed consent
Performance status - GOG 0-2
Laboratory examination WBC3.510(9)/L, Granulocyte count1.510(9)/L, Platelet count8010(9)/L, serum bilirubin 1.5 times the upper limit of normal, transaminase 1.5 times the upper limit of normal, BUN, Creatinine normal Fertile patients must use effective contraception during and for one year after study entry

Exclusion Criteria

Histologically confirmed placental-site trophoblastic tumor (PSTT) or epithelioid trophoblastic tumor (ETT)
primary choriocarcinoma
WHO risk score >4
Previous MTX treatment for suspected ectopic pregnancy
With severe or uncontrolled internal disease, unable to receive chemotherapy
Concurrently participating in other clinical trials
Unable or unwilling to sign informed consents
Unable or unwilling to abide by protocol
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note